Form 4: Ambarella CFO Executes Pre-Planned Stock Sale
Insider Transaction Report
Ambarella CFO John Young exercised stock options and sold 400 shares under a pre-existing Rule 10b5-1 trading plan.
Summary
- CFO John Young exercised 400 non-qualified stock options at a strike price of $55.80.
- Following the exercise, the CFO sold the 400 shares at a market price of $96.00 per share.
- The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on January 15, 2026.
- Post-transaction, the CFO maintains beneficial ownership of 117,623 ordinary shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents a small portion of the executive's total holdings.
Positives
- The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating the sale was not based on non-public information.
- The CFO retains a significant equity stake of 117,623 shares in the company.
Negatives
- The filing reflects a divestment of shares by a key executive, which can sometimes be perceived as a lack of long-term confidence, though this was pre-planned.
Risks
- Reliance on Rule 10b5-1 plans does not eliminate the risk of negative market perception regarding executive selling activity.
Future Outlook
No forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is standard practice for executives to manage personal liquidity and is generally viewed as neutral by the market.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is a standard corporate governance practice among S&P 500 and technology sector executives to ensure compliance with insider trading regulations.
Stakeholder Impact
- Minimal impact on shareholders as the sale was pre-planned and limited in volume.
Next Steps
- No further actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 03/27/2018 | Initial vesting date for the stock options exercised. |
| 01/15/2026 | Adoption date of the Rule 10b5-1 trading plan. |
| 05/26/2026 | Date of the option exercise and subsequent share sale. |
| 05/28/2026 | Date of filing for the Form 4. |
| 03/27/2027 | Expiration date of the remaining stock options. |
Keywords
Ambarella, AMBA, Insider Trading, Form 4, CFO, Stock Options, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.